Security key
471871202
Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR)
CUSIP: 471871202
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Voting Common Stock, par value $0.0001 per share
- Total 13F shares
- 14,557,013
- Total 13F value
- $329,580,756
- Share change
- +1,599,050
- Put/Call ratio
- 23%
- SEC-reported price per share
- $22.70
- Number of holders
- 67
- Value change
- +$34,893,415
- Number of buys
- 41
- Number of sells
- 27
- Shares outstanding
- 33,973,202
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
67
Top holders
10
JSPR full security history
Ownership snapshot
Full 13F holder table
Jasper Therapeutics, Inc. SEC filings
Jasper Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Velan Capital Investment ...
Disclosed value leader
Velan Capital Investment ...
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
3/4/5
Lead comparable stake: 4.3%
Showing 1-6 of 15 holder rows.
Quick read
Velan Capital Investment Management LP leads the comparable SEC ownership view at 4.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Velan Capital Investment Management LP's linked filing trail.
Comparable ownership
Top 5
Velan Capital Investment Manageme...
4.3%
Soleus Capital Management, L.P.
3.5%
Carlyle Group Inc.
3.1%
Qiming U.S. Ventures Management, LLC
2.7%
Avidity Partners Management LP
2.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Velan Capital Investment Management LP |
13F
3/4/5
Company · 10%+ Owner
|
4.3%
|
$42,097,193
1,471,904 shares
|
— | 31 Mar 2024 |
| Soleus Capital Management, L.P. |
13F
Company
|
3.5%
|
$34,853,139
1,187,096 shares
|
— | 31 Mar 2024 |
| Carlyle Group Inc. |
13F
3/4/5
Company · Former 10% Owner
|
3.1%
|
$31,303,309
1,066,189 shares
|
— | 31 Mar 2024 |
| Qiming U.S. Ventures Management, LLC |
13F
Company
|
2.7%
|
$27,274,383
928,964 shares
|
— | 31 Mar 2024 |
| Avidity Partners Management LP |
13F
Company
|
2.2%
|
$22,313,600
760,000 shares
|
— | 31 Mar 2024 |
| FRANKLIN RESOURCES INC |
13F
Company
|
2.1%
|
$21,200,093
722,074 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
67
Shares
14,557,013
Rows available
67
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
56
Q2 2024 holders
67
Holder diff
11
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|